戻る Agenda
Global Clinical Trials: The Role of Emerging Markets
Session Chair(s)
Nancy Meyerson-Hess, MS, MSC
Quality Officer
Emqt, Germany
Reducing the Risks of Integrating Emerging Regions in Global Clinical Trials
Learning Objective : Describe the areas of potential risks when undertaking global clinical trials in emerging markets; Compare industry emerging markets activity and strategy as it relates to overall strategy, patient recruitment practices and randomization; Evaluate the various mechanisms to speed up the clinical trial approval process in the Asia Pacific region.
Speaker(s)
Reducing the Risks of Integrating Emerging Regions in Global Clinical Trials
Nancy Meyerson-Hess, MS, MSC
Emqt, Germany
Quality Officer
Establishment of a Clinical Trial Consortium in the Asia Pacific Region
Guei-Jen Shieh, PHD
Taiwan Supra Integration and Incubation Center, Taiwan
Senior Project Leader
Clinical Trials in Emerging Markets: Trends and Experience Study Highlights
Linda Martin, MBA
KMR Group Inc., United States
President and Founder